InspireMD (NSPR) Income towards Parent Company (2010 - 2025)
InspireMD's (NSPR) quarterly Income towards Parent Company came in at -$75.7 million in Q4 2025, down 30.89% year-on-year from -$109.5 million in Q4 2024, and down 479.66% quarter-over-quarter from -$13.1 million in Q3 2025.
InspireMD (NSPR) Income towards Parent Company (2010 - 2025) Analysis & Trends
InspireMD's Income towards Parent Company history runs 16 years deep, the most recent figure standing at -$75.7 million for Q4 2025.
- On a quarterly basis, Income towards Parent Company fell 30.89% year-over-year to -$75.7 million in Q4 2025; TTM through Dec 2025 was -$113.2 million, a 38.14% decrease from a year earlier, with the FY2025 full-year figure at -$49.9 million, down 97.7% from the prior year.
- Income towards Parent Company declined to -$75.7 million in Q4 2025 per NSPR's latest filing, from -$13.1 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$3.2 million in Q1 2021 and bottomed at -$75.7 million in Q4 2025.
- The 5-year median for Income towards Parent Company is -$5.5 million (2023), against an average of -$13.0 million.
- Across the five-year window, Income towards Parent Company jumped 89.57% in 2021 and slumped 251.69% in 2023, its largest moves.
- Year by year, Income towards Parent Company stood at -$4.1 million in 2021, then fell by 18.88% to -$4.8 million in 2022, then slumped by 251.69% to -$16.9 million in 2023, then tumbled by 241.17% to -$57.8 million in 2024, then plunged by 30.89% to -$75.7 million in 2025.
- Per Business Quant, the three latest NSPR Income towards Parent Company figures stand at -$75.7 million (Q4 2025), -$13.1 million (Q3 2025), and -$13.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn |
| 10 | InspireMD | 43.74 Mn | -10.47 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -75.65 Mn |
| Sep 30, 2025 | -13.05 Mn |
| Jun 30, 2025 | -13.02 Mn |
| Mar 31, 2025 | -11.46 Mn |
| Dec 31, 2024 | -57.80 Mn |
| Sep 30, 2024 | -8.46 Mn |
| Jun 30, 2024 | -8.26 Mn |
| Mar 31, 2024 | -7.41 Mn |
| Dec 31, 2023 | -16.94 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -5.32 Mn |
| Mar 31, 2023 | -4.38 Mn |
| Dec 31, 2022 | -4.82 Mn |
| Sep 30, 2022 | -4.53 Mn |
| Jun 30, 2022 | -4.64 Mn |
| Mar 31, 2022 | -4.48 Mn |
| Dec 31, 2021 | -4.05 Mn |
| Sep 30, 2021 | -4.07 Mn |
| Jun 30, 2021 | -3.51 Mn |
| Mar 31, 2021 | -3.24 Mn |